The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample.
The global Cancer Stem Cells market was valued at US$ 858.9 million in 2023 and is anticipated to reach US$ 1917.8 million by 2030, witnessing a CAGR of 12.0% during the forecast period 2024-2030.
Over the past few years, stem cells are being successfully utilized in immuno-reconstitution and for replenishment of blood after tumor development or after tumor treatment.
This report aims to provide a comprehensive presentation of the global market for Cancer Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Stem Cells.
Report Scope
The Cancer Stem Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Stem Cells companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Thermo Fisher Scientific
- Abbvie
- Merck Kgaa
- Bionomics
- Lonza
- Stemline Therapeutics
- Miltenyi Biotec
- Promocell
- Macrogenics
- Oncomed Pharmaceuticals
- Irvine Scientific
- Stemcell Technologies
- Sino Biological
- Biotime
Segment by Type
- Cell Culturing
- Cell Separation
- Cell Analysis
- Molecular Analysis
- Others
Segment by Application
- Breast Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Colorectal Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Stem Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Stem Cells Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cell Culturing
1.2.3 Cell Separation
1.2.4 Cell Analysis
1.2.5 Molecular Analysis
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cancer Stem Cells Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Breast Cancer Diagnosis and Treatment
1.3.3 Prostate Cancer Diagnosis and Treatment
1.3.4 Colorectal Cancer Diagnosis and Treatment
1.3.5 Lung Cancer Diagnosis and Treatment
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Stem Cells Market Perspective (2019-2030)
2.2 Cancer Stem Cells Growth Trends by Region
2.2.1 Global Cancer Stem Cells Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Stem Cells Historic Market Size by Region (2019-2024)
2.2.3 Cancer Stem Cells Forecasted Market Size by Region (2025-2030)
2.3 Cancer Stem Cells Market Dynamics
2.3.1 Cancer Stem Cells Industry Trends
2.3.2 Cancer Stem Cells Market Drivers
2.3.3 Cancer Stem Cells Market Challenges
2.3.4 Cancer Stem Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Stem Cells Players by Revenue
3.1.1 Global Top Cancer Stem Cells Players by Revenue (2019-2024)
3.1.2 Global Cancer Stem Cells Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Stem Cells Revenue
3.4 Global Cancer Stem Cells Market Concentration Ratio
3.4.1 Global Cancer Stem Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Stem Cells Revenue in 2023
3.5 Cancer Stem Cells Key Players Head office and Area Served
3.6 Key Players Cancer Stem Cells Product Solution and Service
3.7 Date of Enter into Cancer Stem Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Stem Cells Breakdown Data by Type
4.1 Global Cancer Stem Cells Historic Market Size by Type (2019-2024)
4.2 Global Cancer Stem Cells Forecasted Market Size by Type (2025-2030)
5 Cancer Stem Cells Breakdown Data by Application
5.1 Global Cancer Stem Cells Historic Market Size by Application (2019-2024)
5.2 Global Cancer Stem Cells Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Stem Cells Market Size (2019-2030)
6.2 North America Cancer Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cancer Stem Cells Market Size by Country (2019-2024)
6.4 North America Cancer Stem Cells Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Stem Cells Market Size (2019-2030)
7.2 Europe Cancer Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cancer Stem Cells Market Size by Country (2019-2024)
7.4 Europe Cancer Stem Cells Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Stem Cells Market Size (2019-2030)
8.2 Asia-Pacific Cancer Stem Cells Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cancer Stem Cells Market Size by Region (2019-2024)
8.4 Asia-Pacific Cancer Stem Cells Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Stem Cells Market Size (2019-2030)
9.2 Latin America Cancer Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cancer Stem Cells Market Size by Country (2019-2024)
9.4 Latin America Cancer Stem Cells Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Stem Cells Market Size (2019-2030)
10.2 Middle East & Africa Cancer Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cancer Stem Cells Market Size by Country (2019-2024)
10.4 Middle East & Africa Cancer Stem Cells Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cancer Stem Cells Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cancer Stem Cells Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Abbvie
11.2.1 Abbvie Company Detail
11.2.2 Abbvie Business Overview
11.2.3 Abbvie Cancer Stem Cells Introduction
11.2.4 Abbvie Revenue in Cancer Stem Cells Business (2019-2024)
11.2.5 Abbvie Recent Development
11.3 Merck Kgaa
11.3.1 Merck Kgaa Company Detail
11.3.2 Merck Kgaa Business Overview
11.3.3 Merck Kgaa Cancer Stem Cells Introduction
11.3.4 Merck Kgaa Revenue in Cancer Stem Cells Business (2019-2024)
11.3.5 Merck Kgaa Recent Development
11.4 Bionomics
11.4.1 Bionomics Company Detail
11.4.2 Bionomics Business Overview
11.4.3 Bionomics Cancer Stem Cells Introduction
11.4.4 Bionomics Revenue in Cancer Stem Cells Business (2019-2024)
11.4.5 Bionomics Recent Development
11.5 Lonza
11.5.1 Lonza Company Detail
11.5.2 Lonza Business Overview
11.5.3 Lonza Cancer Stem Cells Introduction
11.5.4 Lonza Revenue in Cancer Stem Cells Business (2019-2024)
11.5.5 Lonza Recent Development
11.6 Stemline Therapeutics
11.6.1 Stemline Therapeutics Company Detail
11.6.2 Stemline Therapeutics Business Overview
11.6.3 Stemline Therapeutics Cancer Stem Cells Introduction
11.6.4 Stemline Therapeutics Revenue in Cancer Stem Cells Business (2019-2024)
11.6.5 Stemline Therapeutics Recent Development
11.7 Miltenyi Biotec
11.7.1 Miltenyi Biotec Company Detail
11.7.2 Miltenyi Biotec Business Overview
11.7.3 Miltenyi Biotec Cancer Stem Cells Introduction
11.7.4 Miltenyi Biotec Revenue in Cancer Stem Cells Business (2019-2024)
11.7.5 Miltenyi Biotec Recent Development
11.8 Promocell
11.8.1 Promocell Company Detail
11.8.2 Promocell Business Overview
11.8.3 Promocell Cancer Stem Cells Introduction
11.8.4 Promocell Revenue in Cancer Stem Cells Business (2019-2024)
11.8.5 Promocell Recent Development
11.9 Macrogenics
11.9.1 Macrogenics Company Detail
11.9.2 Macrogenics Business Overview
11.9.3 Macrogenics Cancer Stem Cells Introduction
11.9.4 Macrogenics Revenue in Cancer Stem Cells Business (2019-2024)
11.9.5 Macrogenics Recent Development
11.10 Oncomed Pharmaceuticals
11.10.1 Oncomed Pharmaceuticals Company Detail
11.10.2 Oncomed Pharmaceuticals Business Overview
11.10.3 Oncomed Pharmaceuticals Cancer Stem Cells Introduction
11.10.4 Oncomed Pharmaceuticals Revenue in Cancer Stem Cells Business (2019-2024)
11.10.5 Oncomed Pharmaceuticals Recent Development
11.11 Irvine Scientific
11.11.1 Irvine Scientific Company Detail
11.11.2 Irvine Scientific Business Overview
11.11.3 Irvine Scientific Cancer Stem Cells Introduction
11.11.4 Irvine Scientific Revenue in Cancer Stem Cells Business (2019-2024)
11.11.5 Irvine Scientific Recent Development
11.12 Stemcell Technologies
11.12.1 Stemcell Technologies Company Detail
11.12.2 Stemcell Technologies Business Overview
11.12.3 Stemcell Technologies Cancer Stem Cells Introduction
11.12.4 Stemcell Technologies Revenue in Cancer Stem Cells Business (2019-2024)
11.12.5 Stemcell Technologies Recent Development
11.13 Sino Biological
11.13.1 Sino Biological Company Detail
11.13.2 Sino Biological Business Overview
11.13.3 Sino Biological Cancer Stem Cells Introduction
11.13.4 Sino Biological Revenue in Cancer Stem Cells Business (2019-2024)
11.13.5 Sino Biological Recent Development
11.14 Biotime
11.14.1 Biotime Company Detail
11.14.2 Biotime Business Overview
11.14.3 Biotime Cancer Stem Cells Introduction
11.14.4 Biotime Revenue in Cancer Stem Cells Business (2019-2024)
11.14.5 Biotime Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
